| [1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61 (2): 69-90.
|
| [2] |
Zheng RS, Zhang SW, Wu LY, et al. Report of incidence and mortality from China cancer registries in 2008[J]. Zhongguo Zhong Liu, 2012, 21(1): 1-12.[郑荣寿, 张思维, 吴良有, 等. 中国 肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 20 12, 21(1): 1-12.]
|
| [3] |
Zhang HQ, Xie M, He B, et al. Clinicopathological features and prognostic factors of gastric cancer patients with malignant ascites: analysis of 223 cases[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2013, 21 (27): 2826-31. [张慧卿, 谢梅, 何波, 等.胃癌恶性腹水患者的 临床特征及预后分析223例[J]. 世界华人消化杂志, 2013, 21(27): 28 26-31.]
|
| [4] |
Cavazzoni E, Bugiantella W, Graziosi L, et al. Malignant ascites: pathophysiology and treatment[J]. Int J Clin Oncol, 2013, 18(1): 1-9.
|
| [5] |
Zhang HQ, Fang N, Lu S, et al. Chloroquine promotes DDPinduced apoptosis in human gastric cancer cell line SGC7901[J]. Zhongguo Zhong Liu Lin Chuang, 2013, 40(16): 947-50. [张慧卿, 方念, 芦珊, 等. 氯喹促进顺铂诱导胃癌SGC7901细胞凋亡及其 机制[J] 中国肿瘤临床, 2013, 40(16): 947-50.]
|
| [6] |
Wang T, Wang L, Qian X, et al. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites[J]. Cancer Invest, 2011, 29(2): 130-6.
|
| [7] |
Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study[J]. Ann Oncol, 2007, 18(5): 945-9.
|
| [8] |
Wimberger P, Gilet H, Gonschior AK, et al. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone[J]. Ann Oncol, 2012, 23(8): 1979-85.
|
| [9] |
Jones AL, Trott P, Cunningham D, et al. A pilot study of intraperitoneal cisplatin in the management of gastric cancer[J]. Ann Oncol, 1994, 5(2): 123-6.
|
| [10] |
Levine B, Kroemer G. Autophagy in the pathogenesis of disease[J]. Cell, 2008, 132(1): 27-42.
|
| [11] |
Huang J, Ni J, Liu K, et al. HMGB1 promotes drug resistance in osteosarcoma[J]. Cancer Res, 2012, 72(1): 230-8.
|
| [12] |
Zhang HQ, He B, Fang N, et al. Autophagy inhibition sensitizes cisplatin cytotoxicity in human gastric cancer cell line SGC7901[J]. Asian Pac J Cancer Prev, 2013, 14(8): 4685-8.
|
| [13] |
Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein[J]. Cell Res, 2007, 17(10): 83 9-49.
|
| [14] |
Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy[J]. Autophagy, 2012, 8(4): 445-544.
|
| [15] |
Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy[J]. Autophagy, 2008, 4(5): 60 0-6.
|
| [16] |
Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis[J]. Cell Death Differ, 2011, 18(4): 57 1-80.
|
| [17] |
O'Donovan TR, O'Sullivan GC, McKenna SL. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics [J]. Autophagy, 2011, 7(5): 509-24.
|
| [18] |
Liu Y, Yang T, Huang CQ, et al. Intraperitoneal chemotherapy for peritoneal carcinomatosis improves efficacy with acceptable safety: results of 200 cycles for 41 patients[J]. Hepatogastroenterology, 2014, 61(130): 373-8.
|
下载:
